Header image

EUROPE’S BIOTECH MOMENT: WHAT THE BIOTECH ACT MUST DELIVER

Tracks
AUDITORIUM MARGARITA SALAS
Tuesday, September 29, 2026
12:15 - 13:00
AUDITORIUM MARGARITA SALAS

Overview

Sponsor: MSD


Details

The year 2025 has been marked by the Biotech Act, the proposed Regulation through which the European Commission aims to establish a comprehensive regulatory framework to foster investment, innovation, and competitiveness in the biotechnology sector at a pivotal moment for Europe's strategic autonomy. Against this backdrop, this session will explore how the Biotech Act represents an opportunity to strengthen the competitiveness of the Spanish biotechnology sector. In particular, the discussion will focus on some of the proposals expected to have the greatest impact on the industry, including Strategic Projects, financing pilots, the extension of the Supplementary Protection Certificate (SPC), and measures to accelerate clinical trials.


Details

Laura Pellisé
Government Affairs Director
Amgen

Moderator

Ms Cristina Nadal Sanmartin
Executive Director of Policy, MSD in Spain and President of AseBio
AseBio - Spanish Bioindustry Association

.

Javier Padilla Benáldez
Secretary of State
Ministry of Health

.

loading